How many employees does Oxford Gene Technology IP Limited have?

Oxford Gene Technology IP Limited reported an average of 13 employees in the year to 31 Mar 2025.

Company No. 03845467 · Incorporated 21 Sep 1999

Oxford Gene Technology IP Limited

Q: Is Oxford Gene Technology IP Limited profitable?

No — Oxford Gene Technology IP Limited reported a loss of £2.3m in the year to 31 Mar 2025.

Registered name: OXFORD GENE TECHNOLOGY IP LIMITED

Oxford Gene Technology IP Limited made a £2.3m loss in the year to 31 Mar 2025 (revenue not disclosed).

Oxford Gene Technology IP Limited reported a loss of £2.3m in the year to 31 Mar 2025; its revenue was not disclosed. It had 13 employees. The company is classified under “research and experimental development on biotechnology” and is based in Kidlington; we hold 4 years of its filed accounts.

Profit onlySection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology

Status: Active
Location: Kidlington, South East
Age: 27 yrs · since 1999
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2025

Key figures

Revenue

—

Not disclosed in filing

Profit

−£2.3m

Growth —

Profit margin

—

Employees

Change 0%

Profit / employee

−£175k

Profitable streak

0yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024	31 Mar 2025
Disclosure	Profit only	Profit only	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—	—
Operating profit	−£1.9m	−£1.9m	−£2.4m	−£2.3m
Profit before tax	−£1.9m	−£1.9m	−£2.4m	−£2.3m
Profit after tax	−£1.9m	−£1.9m	−£2.4m	−£2.3m
Profit (best available)	−£1.9m	−£1.9m	−£2.4m	−£2.3m
Staff costs	£1.2m	£1.1m	£1.4m	£1.1m
Employees (average)	13	13	13	13
Ratios
Profit margin	—	—	—	—
Profit per employee	−£146k	−£147k	−£181k	−£175k
Growth (year on year)
Headcount growth	—	0%	0%	0%
Balance sheet — indirect signals, not revenue
Cash at bank	£160k	£433k	£408k	£173k
Net assets	−£3.1m	−£5m	−£7.4m	−£9.7m
Fixed assets	£17.5m	£17.5m	£17.5m	£17.6m
Current assets	£16.8m	£15m	£12.9m	£11.2m
Debtors	£16.6m	£14.6m	£12.5m	£11m
Deferred income	£279k	£325k	£628k	£595k
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: −£175k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now −£9.7m
Cash at bank: ▼57%; Now £173k
Headcount: 0%; Now 13
Deferred income: ▼5%; Now £595k
Fixed assets: ▲0%; Now £17.6m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Sysmex Corporation (registered outside the UK register)ultimate parent75–100%
Oxford Gene Technology IP Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (4)

Cytocell LimitedRev. £15.5m · Profit £3.4m
Oxford Gene Technology (Operations) LtdRev. £10.3m · Profit −£353k
Oxford Gene Technology (Southern) LimitedRev. — · Profit −£581
Oxford Gene Technology LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit −£2.3m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.